Common bile duct stones
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age >=18 years; 2. Diagnosed with common bile duct stones (CBDS) and scheduled for ERCP treatment; 3. Stones can be successfully removed by ERCP or are expected to be completely removed; 4. Agree to participate in the study and sign written informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients in whom common bile duct stones cannot be successfully cleared during ERCP; 2. Patients with a single common bile duct stone 1.5) or thrombocytopenia (platelet count < 50 × 10?/L); 5. Patients currently taking anticoagulants or antiplatelet agents that cannot be temporarily discontinued; 6. Patients with a history of gastrectomy with Roux-en-Y reconstruction or Billroth II surgery; 7. Patients with concurrent malignant hepatobiliary or pancreatic tumors, or common bile duct stricture; 8. Patients with concurrent severe liver disease, acute moderate-to-severe pancreatitis, or acute moderate-to-severe suppurative cholangitis; 9. Patients with concurrent primary sclerosing cholangitis, Mirizzi syndrome, or intrahepatic bile duct stones; 10. Patients with cholecystoduodenal fistula or recent gastrointestinal bleeding; 11. Pregnant women; 12. Other conditions deemed inappropriate for enrollment by the investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of post-ERCP cholangitis; | — |
Secondary
| Measure | Time frame |
|---|---|
| Recurrence rate of common bile duct stones;Total ERCP operation time;Fluoroscopy time;Irrigation time;Postoperative hospital stay;Hospitalization costs;Re-intervention rate due to intervention;Mortality rate; | — |
Countries
China
Contacts
The First Hospital of Lanzhou University